Retatrutide is a new treatment in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By boosting these receptors, https://jeangrld568496.digiblogbox.com/60767514/setmelanotide-a-promising-new-treatment-for-obesity